CytoReason
PrivateLast Round
Series C
Jul 17, 2024
Total Funding Raised
$132.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CytoReason is a biotechnology company that offers cell-based models and data analysis services to create computational models of the human body for simulating diseases at the cellular level.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, ML Platforms, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoReason Comps
Public and private peers based on sector, stage, and business model.
CytoReason Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 17, 2024 | ||||
| Series B | Sep 20, 2022 | ||||
| Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
CytoReason Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pico Venture Partners | Series A, Seed |
| Pfizer | Series C, Series B |
| Bank Hapoalim | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
Launched new product at the JPM HealthCare Conference 2026.
- Jan 15, 2026
Launched an AI chat-style assistant for pharma R&D.
CytoReason Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoReason's valuation, stock price, and market status.
